InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Sklawer Andrew D, Chief Executive Officer. Officer active across 2 companies, notably Brickell Biotech, Inc.. Cumulatively, 2 reports have been recorded. Total volume traded: €20k. The latest transaction was disclosed on 17 May 2021 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
€10,11815,375 shares@ €0.6581100.0% of flow
Common Stock
SEC:0001062993-21-004868·
Ideal exit: 11 Feb 2022 (T+270)
€10,11815,375 shares@ €0.658150.0% of flow
Common Stock
SEC:0001062993-21-004868:0·
Ideal exit: 11 Feb 2022 (T+270)
2 of 2 declarations
About Sklawer Andrew D
Sklawer Andrew D is the COO and Secretary at Brickell Biotech, Inc. He oversees the company's operations and ensures compliance of processes. His role is essential for the effective management of the organization.
